ZAMPERINI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 2.291
EU - Europa 1.875
AS - Asia 300
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
AF - Africa 1
Totale 4.476
Nazione #
US - Stati Uniti d'America 2.284
GB - Regno Unito 631
IE - Irlanda 390
IT - Italia 341
CN - Cina 217
SE - Svezia 180
UA - Ucraina 125
FR - Francia 75
DE - Germania 60
FI - Finlandia 30
VN - Vietnam 30
TR - Turchia 27
BE - Belgio 15
ES - Italia 10
NL - Olanda 10
IN - India 7
IR - Iran 7
CA - Canada 6
BR - Brasile 3
EU - Europa 3
JP - Giappone 3
AU - Australia 2
NO - Norvegia 2
RO - Romania 2
SG - Singapore 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
HK - Hong Kong 1
HU - Ungheria 1
IQ - Iraq 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
PA - Panama 1
UZ - Uzbekistan 1
Totale 4.476
Città #
Southend 593
Dublin 382
Fairfield 340
Chandler 219
Ashburn 185
Siena 172
Menlo Park 169
Woodbridge 167
Wilmington 148
Jacksonville 127
Cambridge 124
Seattle 120
Ann Arbor 112
Houston 100
Beijing 66
New York 61
Princeton 53
Nanjing 44
Dearborn 34
Dong Ket 30
Shanghai 26
Izmir 21
Fremont 18
Boardman 17
San Mateo 17
Helsinki 16
San Diego 16
Brussels 15
Milan 14
Florence 13
Nanchang 12
Venezia 11
Düsseldorf 10
Málaga 10
Redwood City 8
Tianjin 8
Hebei 7
Jinan 7
Amsterdam 6
Changsha 6
Hefei 6
Rome 6
Shenyang 6
Jiaxing 5
Lancaster 5
London 5
Paris 5
Zanjan 5
Kunming 4
Los Angeles 4
Norwalk 4
Phoenix 4
Toronto 4
Andover 3
Detroit 3
Napoli 3
San Francisco 3
Washington 3
Zhengzhou 3
Bagno a Ripoli 2
Bangalore 2
Castelvetere in Val Fortore 2
Castiglione del Lago 2
Frankfurt am Main 2
Kilburn 2
Kocaeli 2
Madison 2
Manchester 2
Ningbo 2
Oslo 2
Padova 2
Prescot 2
Utrecht 2
Winnipeg 2
Yenibosna 2
Agliana 1
Alezio 1
Avellino 1
Baghdad 1
Baku 1
Bicinicco 1
Bishkek 1
Bologna 1
Cairo 1
Canberra 1
Castelvetrano 1
Cedar Rapids 1
Central 1
Chengdu 1
Chicago 1
Chiswick 1
Cologno Monzese 1
Cosenza 1
Cremona 1
Edinburgh 1
Ergolding 1
Falkenstein 1
Garching 1
Haikou 1
Hounslow 1
Totale 3.642
Nome #
Prodrugs of pyrazolo[3,4-d]pyrimidines: from library synthesis to evaluation as potential anticancer agents in an orthotopic glioblastoma model 259
Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents 220
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents 206
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 203
Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line 198
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma. 186
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. 182
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 175
Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization 174
DDX3X Helicase Inhibitors as a New Strategy to Fight the West Nile Virus Infection 170
New Pyrazolobenzothiazine Derivatives as Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 169
Design, synthesis, biological activity and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study 166
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 166
2-Aminothiazolones as anti-hiv agents that act as gp120-cd4 inhibitors 161
Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4- d]pyrimidines for Targeting Hepatocellular Carcinoma 155
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant 152
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 152
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 149
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells. 145
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 145
null 143
Presence of Destruxin A and Beauvericin in cereals 140
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors 139
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model:from in silico screening to cyclodextrin formulation 134
Synthesis, biological activity, and ADME properties of novel S-DABOs/N-DABOs as HIV reverse transcriptase inhibitors. 122
In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains 99
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma 91
Tyrosine Kinase Inhibitor Si409 Has In Vitro and In Vivo Anti-Tumor Activity Against Diffuse Large B-Cell Lymphoma 58
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma 47
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides 38
null 14
Totale 4.558
Categoria #
all - tutte 12.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019343 0 0 0 0 0 0 0 0 0 73 134 136
2019/20201.036 120 42 58 148 93 109 86 115 85 91 36 53
2020/2021653 28 56 21 56 32 79 29 77 50 120 50 55
2021/2022560 39 66 38 23 40 19 27 19 36 83 72 98
2022/2023664 35 100 70 95 64 104 40 44 59 22 24 7
2023/2024617 31 8 41 32 30 195 234 22 0 24 0 0
Totale 4.558